Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GOSS

Gossamer Bio, Inc.

CIK 0001728117 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.15
↓ 0.00 (-1.78%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$75.62M
P/E Ratio
-0.60
EPS
-0.75
Dividend Yield
Not covered
52W Position
1%
Beta
2.18

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.80
P/S
1.42
EV/Revenue
0.65
ROE
133.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$0.11$3.87

Latest Financials

2025-12-31 FY
Revenue
$48.47M
Net Income
-$170.37M
Total Assets
$172.25M
Free Cash Flow
-$171.34M

Recent news